Abstract
Introduction
Ovarian cancer includes a variety of several histopathological entities; the most frequent one is the epithelial cancer (about 90%) even if other subtypes may occur; the diagnosis and the treatment depend on the specific tumor [1, 2] . It is the fifth most common cancer in US and the number of new diagnosis is around 22,000 in 2016, with the prevalence in the sixth and seventh decades [3] .
The risk factors are: nulliparity, older age at the first pregnancy, post-menopausal hormone therapy, pelvic inflammatory disease, and positive family history (including linking to BRCA1 and BRCA2 genotypes, affection by Lynch syndrome) [4] [5] [6] [7] .
Case Report
We present a case of 57 years old woman who had in 2013 a bilateral ovarian adenocarcinoma. Her medical history was positive for obesity, diabetes mellitus and laparoscopic cholecystectomy. She underwent an explorative laparotomy. The gynecologist decided to perform a bilateral salpingo-ovaro annessiectomy, an enblock Douglasectomy, a bilateral pelvic lymphadenectomy, an appendicectomy and a inframesocolic omentectomy. The definitive histological response confirmed the preoperative diagnosis: a bilateral endometrioid adenocarcinoma with omental metastasis without the involvement of lymph nodes (pT3c/G2/pN0; Figo IIIC stage). After one month, she started the adjuvant chemotherapy with Carbo Auc 5 Taxolo and she finished all the cycles in May 2013 with a complete remission.
Symptoms suggestive of ovarian cancer include: bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, urinary problems like urgency or frequency [8] . There are no screening tests available, but woman with high risk should get deeper evaluation [9] .
Primary treatment consists of appropriate surgical staging, followed very often by a systemic chemotherapy [10] . After initial treatment, the patient should undergo clinical re-evaluation and follow-up. Ovarian cancer has a property of persistence after primary surgery and chemotherapy even in early stages, so it is very important to have an accurate diagnosis of recurrence in order to follow up these patients properly. Recurrent disease may be identify clinically, biochemically and with imaging (ultrasound, chest and abdomen CT scan and FDG-PET scan if clinically necessary) [11] .
In the next years, she underwent a correct follow up with the dosage of biochemical markers, CT scan and PET scan, all negative. In September 2016 during a PET scan, it was visible a big hypo dense photopenic area (around 12x13 cm), localized in front of and under the left kidney, without 18F-FDG enhancing. The patient did not complain any symptoms related. She had also a CT scan, which confirmed the presence of a big anaecogen area with cystic aspect with irregular tick wall in the left abdomen. The meantime, all biochemical markers (CEA, CA 19.9, CA 125) were negative. She underwent also an ultrasound guided ago biopsy of the lesion and the cytological exam was suitable to a cystic formation, negative for cancer cells. 
Discussion
Ovarian cancer has been recently divided into two groups: type I involve low grade serous carcinoma of low grade, low grade of endometrioid carcinoma, clear cells carcinoma, mucinous carcinoma and Brenner tumors. These neoplasms have a good prognosis, rarely present mutations of p53 gene and are genetically stable; type II, represent the 75% of cases, include high-grade serous carcinoma, high-grade endormetrioid carcinoma, not differentiated carcinoma and carcinosarcoma. They have aggressive biological behavior, they are diagnosed in ad advanced stage, and they have p53 gene mutation and in the 80% of cases are genetically unstable [12] .
Endometrioid carcinomas account for 8-15% of all ovarian carcinomas and it is the second commonest malignant ovarian neoplasm. These tumors appear similar to other epithelial lesions, with variable cystic and solid components. Histologically, an endometrioid carcinoma is characterized by the appearance of tubular glands [13] .
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Ovarian cancer has the propency to recurrence even after primary surgery and chemotherapy. The most frequent pattern of spread is the Trans colonic route, even if the intraperitoneal, lymphatic and haematogenous ones may occur [15] .
The serum Ca 125 is commonly used, but it is not accurate because the normal serum level doesn't exclude the presence of the disease and doesn't give any information on the site. A negative Ca125 has been seen in patients with residual tumor after surgical procedure.
The imaging such as ultrasound, CT scan and MRI has a role in the characterization of the disease recurrence, even if it's not so certain for determining the disease status.
Positron emission tomography with FDG might represent a valid option is staging and following up a wide variety of neoplasm, even if it hasn't been definitively established [17] . Evaluated the use of 18FDG-PET as a prior test to plan surgical second look and it was positive just in the half of the analyzed patients.
So the best follow up technique is still controversial and there are no unique guidelines to respect.
In most part of surgical centers a second look surgery might be acceptable, because it might be considered the best method to define the disease status; even if it's not helpful with not visible metastasis and long distance lesions. 
